Cyclosporin A in cadaveric organ transplantation.
- 21 March 1981
- Vol. 282 (6268) , 934-936
- https://doi.org/10.1136/bmj.282.6268.934
Abstract
The use of cyclosporin A (CyA) with a protocol designed to avoid the effects of nephrotoxicity resulted in a one-year survival of 86% in recipients of renal allografts from unmatched cadaveric donors. The drug also controlled rejection of liver and pancreatic allografts. It was possible to change patients initially treated with CyA to azathioprine and corticosteroids and vice versa, thus enlarging the potential value of CyA in organ allografting. Of 34 recipients of renal allografts, 29 were currently receiving only CyA as immunosuppressive treatment. Twelve patients never required any adjuvant steroid treatment. These results suggest that CyA is an effective immunosuppressant, and if used with care side effects need not be severe.Keywords
This publication has 9 references indexed in Scilit:
- TWO CASES OF BENIGN LUMPS AFTER TREATMENT WITH CYCLOSPORIN AThe Lancet, 1980
- Prolongation of canine pancreas allograft survival with cyclosporin A: preliminary report.BMJ, 1980
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- THE USE OF CYCLOSPORIN-A AND PREDNISONE IN CADAVER KIDNEY-TRANSPLANTATION1980
- Prolamine solution to block pancreatic duct.1979
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORSThe Lancet, 1978
- NEW METHOD OF PREPARATION OF SEGMENTAL PANCREATIC GRAFTS FOR TRANSPLANTATION - TRIALS IN DOGS AND IN MAN1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958